Article
Establishment of<i>in silico</i>prediction of adjuvant chemotherapy response from active mitotic gene signature in non-small cell lung cancer
2025-03-15
Abstract excerpt
Conventional chemotherapeutics exploit cancer’s hallmark of active cell cycling, primarily targeting mitotic cells. Consequently, the mitotic index (MI), representing the proportion of cells in mitosis, serves as both a prognostic biomarker for cancer progression and a predictive marker for chemo-responsiveness. In this study, we developed a transcriptome signature to predict the chemotherapeutic responsiveness ba...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3174c481-1a3f-5e88-83e1-fdd85253ad98
- DOI
- 10.1101/2025.03.14.25322930
